Patents/Assignees

Prevail Therapeutics, Inc.

11 patents in portfolio

US12570963utility2026
Gene Therapies for Lysosomal Disorders
0 cites
US12571002utility2026
Gene Therapies for Lysosomal Disorders
0 cites
US12049626utility2024
Gene Therapy for Neurodegenerative Disorders
0 cites
US11999974utility2024
Gene Therapies for Lysosomal Disorders
0 cites
US11993790utility2024
Gene Therapies for Lysosomal Disorders
0 cites
US11903985utility2024
Gene Therapies for Lysosomal Disorders
0 cites
US11807849utility2023
Gene Therapies for Lysosomal Disorders
0 cites
US11802294utility2023
Gene Therapies for Lysosomal Disorders
0 cites
US11661585utility2023
Gene Therapies for Lysosomal Disorders
0 cites
US11655460utility2023
Gene Therapies for Lysosomal Disorders
0 cites
US11613737utility2023
Gene Therapies for Lysosomal Disorders
0 cites